查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1736771

全球生物加工技术市场：按产品、应用、最终用户、区域范围和预测

Global Bioprocess Technology Market By Product, By Application, By End User, By Geographic Scope and Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格

生物加工技术的市场规模与预测

2024 年生物加工技术市场规模价值 287 亿美元，预计到 2032 年将达到 603 亿美元，在 2026-2032 年预测期内的复合年增长率为 10.70%。

生物加工技术是指利用活细胞及其成分来开发产品和工艺，以提高生物材料的产量。

该技术对于各种应用都至关重要，包括药品、酵素、生质燃料和食品的生产，因为它利用生物系统实现效率和永续性。

生物加工技术的未来前景光明，合成生物学、基因组学和自动化领域的进步有望带来更有效率的生产方法以及个人化医疗、可再生能源和永续农业等领域的创新应用。

生物加工技术的全球市场动态

影响全球生物加工技术市场的关键市场动态是：

关键市场驱动因素

生物製药需求不断增长：受慢性病发病率上升和个人化医疗技术进步的推动，生物製药行业正在快速扩张。根据《2023年全球生物製药市场报告》，预计2025年，生物製药市场规模将达到3.8兆美元，复合年增长率为8.6%。

生物技术进步：包括基因编辑和合成生物学在内的生物技术创新正在提高生物过程的效率和生产力。根据美国国立卫生研究院 (NIH) 的报告，2021 年生物技术研发投资将达到约 650 亿美元，显示该领域技术进步的强劲投入。

更重视永续性：各行各业越来越重视永续实践，尤其是在生质燃料和生物分解性材料的生产领域。根据国际可再生能源机构 (IRENA) 的报告，全球生质燃料市场预计将以 6.5% 的复合年增长率成长，到 2027 年达到 1,850 亿美元。

政府支持和资金：世界各国政府正在提供大量资金和奖励，以支持生物加工技术的发展。例如，美国能源局(DOE) 宣布将在 2023 年投资 5,700 万美元用于生质能源技术的开发，这反映了政府对生物加工创新的大力支持。

主要问题

监管障碍：生物製程技术领域面临复杂的监管要求，这会延迟产品核准、增加成本，并需要大量时间和资源来应对。

生产成本高：生物加工技术（包括设备和原材料）的初始投资可能很大，导致生产成本高，并可能阻碍中小企业进入市场。

可扩展性问题：从实验室规模的流程转向商业规模的生产可能会带来一些挑战，例如在扩大规模的过程中保持产品品质和一致性。

人才短缺：生物加工领域对熟练专业人员的需求正在成长，但合格人才的短缺可能会限制产业的创新和发展。

主要趋势

自动化和人工智慧的整合：自动化和人工智慧在生物加工中的应用日益广泛，提高了效率，减少了人为错误，并实现了流程的即时监控和最佳化。

转向连续处理：人们正在转向连续生物处理，这比传统的批量处理具有优势，包括更短的生产时间和更高的产品品质。

关注个人化医疗：个人化医疗的兴起正在推动生物加工技术的创新，从而发展出适合个别患者需求的治疗方法。

永续实践和绿色技术：根据全球永续性目标，人们越来越多地采用永续实践和环保技术，例如使用可再生资源和减少废弃物。

目录

第一章 引言

  • 市场定义
  • 市场区隔
  • 调查时间表
  • 先决条件
  • 限制

第二章调查方法

  • 资料探勘
  • 二次研究
  • 初步研究
  • 专家建议
  • 品质检查
  • 最终审核
  • 数据三角测量
  • 自下而上的方法
  • 自上而下的方法
  • 调查流程
  • 资料来源
  • 业界专家的重要见解

第三章执行摘要

  • 市场概览
  • 全球生物加工技术生态系图谱
  • 全球生物加工技术市场的吸引力
  • 全球生物加工技术绝对商机
  • 全球生物加工技术市场的地理洞察
  • 全球生物加工技术市场（按类型）
  • 全球生物加工技术市场（按应用）
  • 全球生物加工技术市场（按最终用户划分）
  • 未来市场机会
  • 全球市场区隔

第四章 市场展望

  • 生物工艺技术全球市场展望
  • 市场驱动因素
    • 疾病负担加重。
    • 外包生物製程开发趋势日益增长
  • 市场限制
    • 资金投入高、设备昂贵
    • 严格的政府法规。
  • 可能性
    • 增加对生技研发的投资
    • 强大的生物製药产品线
  • COVID-19对全球市场的影响
  • 波特五力分析
    • 新进入者的威胁
    • 替代品的威胁
    • 供应商的议价能力
    • 买家的议价能力
    • 竞争对手之间的竞争强度
  • 宏观经济分析
  • 价值链分析

第五章 按产品分類的市场

  • 概述
  • 生物加工设备
  • 生物加工服务

第六章 按应用分類的市场

  • 概述
  • 製药
  • 生物技术
  • 饮食
  • 环境管理

第七章 终端用户市场

  • 概述
  • 生物製药公司
  • 学术和研究机构
  • 受託製造厂商

第八章 区域市场

  • 概述
  • 北美洲
    • 北美市场概述
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲市场概述
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 亚太市场概述
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 拉丁美洲
    • 拉丁美洲市场概述
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 中东和非洲
    • 中东和非洲市场概述
    • 阿拉伯聯合大公国
    • 沙乌地阿拉伯
    • 南非
    • 其他中东和非洲地区

第九章 竞争态势

  • 概述
  • 竞争场景
  • 各公司市场排名分析
  • 区域足迹
  • 公司在各行业的足迹
  • 王牌矩阵
    • 积极的
    • 前线
    • 新兴
    • 创新者

第十章 公司简介

  • GE HEALTHCARE COMPANY
  • THERMO FISHER SCIENTIFIC
  • DANAHER CORPORATION
  • LCG GROUP
  • MERCK GROUP
  • LONZA GROUP AG
  • SARTORIUS AG.
  • CORNING INCORPORATED
  • BIO-RAD LABORATORIES, INC.
Product Code: 40850

Bioprocess Technology Market Size And Forecast

Bioprocess Technology Market size was valued at USD 28.7 Billion in 2024 and is projected to reach USD 60.3 Billion by 2032, growing at a CAGR of 10.70% from 2026 to 2032.

Bioprocess technology refers to the use of living cells or their components to develop products and processes that enhance the production of biological materials.

This technology is pivotal in various applications, including the production of pharmaceuticals, enzymes, biofuels, and food products, as it leverages biological systems for efficiency and sustainability.

The future of bioprocess technology is promising, driven by advancements in synthetic biology, genomics, and automation, which are expected to lead to more efficient production methods and innovative applications in fields such as personalized medicine, renewable energy, and sustainable agriculture.

Global Bioprocess Technology Market Dynamics

The key market dynamics that are shaping the global bioprocess technology market include:

Key Market Drivers:

Growing Demand for Biopharmaceuticals: The biopharmaceutical sector is expanding rapidly, driven by the increasing prevalence of chronic diseases and advancements in personalized medicine. According to the Global Biopharmaceutical Market Report 2023, the market is expected to reach USD 3.8 trillion by 2025, growing at a compound annual growth rate (CAGR) of 8.6%.

Advancements in Biotechnology: Innovations in biotechnology, including gene editing and synthetic biology, are enhancing the efficiency and productivity of bioprocesses. A report from the National Institute of Health (NIH) highlights those investments in biotechnology research and development reached approximately USD 65 billion in 2021, indicating a strong commitment to technological advancements in this field.

Increasing Focus on Sustainability: There is a growing emphasis on sustainable practices in various industries, particularly in the production of biofuels and biodegradable materials. The International Renewable Energy Agency (IRENA) reports that the global biofuels market is projected to grow at a CAGR of 6.5%, reaching USD 185 billion by 2027.

Government Support and Funding: Many governments worldwide are providing substantial funding and incentives to support bioprocess technology development. For instance, the U.S. Department of Energy (DOE) announced an investment of USD 57 million in 2023 to advance bioenergy technologies, reflecting strong governmental backing for bioprocess innovations.

Key Challenges:

Regulatory Hurdles: The bioprocess technology sector faces complex regulatory requirements that can delay product approvals and increase costs. Navigating these regulations requires significant time and resources.

High Production Costs: The initial investment for bioprocess technology, including equipment and raw materials, can be substantial, leading to high production costs that may hinder market entry for smaller companies.

Scalability Issues: Transitioning from laboratory-scale processes to commercial-scale production can pose challenges, including maintaining product quality and consistency during scale-up.

Talent Shortage: There is a growing demand for skilled professionals in bioprocessing, but a shortage of qualified personnel can limit innovation and development within the industry.

Key Trends:

Integration of Automation and AI: The increasing use of automation and artificial intelligence in bioprocessing is enhancing efficiency, reducing human error, and enabling real-time monitoring and optimization of processes.

Shift towards Continuous Processing: There is a trend toward continuous bioprocessing, which offers advantages over traditional batch processing, such as reduced production time and improved product quality.

Focus on Personalized Medicine: The rise of personalized medicine is driving innovation in bioprocess technology, leading to the development of tailored therapies that meet individual patient needs.

Sustainable Practices and Green Technologies: The industry is increasingly adopting sustainable practices and green technologies, such as using renewable resources and minimizing waste, to align with global sustainability goals.

Global Bioprocess Technology Market Regional Analysis

Here is a more detailed regional analysis of the global bioprocess technology market:

North America:

North America is the dominant region in the global bioprocess technology market, driven by its advanced biotechnology infrastructure, robust research and development initiatives, and strong presence of major pharmaceutical companies. The region is home to a large number of biopharmaceutical firms that invest heavily in innovative bioprocessing technologies. According to a report by the Biotechnology Innovation Organization (BIO), the U.S. biopharmaceutical sector generated over $300 billion in revenue in 2023, highlighting the significant economic impact of bioprocess technologies.

Additionally, government initiatives and funding have further supported the growth of the bioprocess technology sector. For instance, the National Institutes of Health (NIH) has allocated approximately $50 billion annually to support biomedical research, including advancements in bioprocessing technologies. This financial backing encourages the development and commercialization of new biopharmaceutical products, reinforcing North America's leadership in the market.

Asia Pacific:

The Asia Pacific region is the fastest-growing market for bioprocess technology, driven by rapid industrialization, increasing healthcare demands, and significant investments in biotechnology. Countries like China and India are emerging as key players due to their growing biopharmaceutical sectors and expanding manufacturing capabilities. According to a report by the Asian Development Bank (ADB), the biotechnology market in Asia is projected to grow at a CAGR of over 15% from 2024 to 2030, underscoring its rapid expansion.

Additionally, the supportive government policies in countries like China, which includes the "Made in China 2025" initiative aimed at enhancing the biotechnology sector, are propelling market growth. The increasing focus on research and development in bioprocess technologies to meet the rising demand for biologics and biosimilars is further driving this growth trajectory in the Asia Pacific region.

Global Bioprocess Technology Market: Segmentation Analysis

The Global Bioprocess Technology Market is segmented on the basis of Product, Application, End User, and Geography.

Bioprocess Technology Market, By Product

  • Bioprocess Instruments
  • Bioprocess Services

Based on Product, the Global Bioprocess Technology Market is segmented into Bioprocess Instruments and Bioprocess Services. The bioprocess instruments is the dominating segment, driven by the demand for advanced equipment such as bioreactors, fermenters, and analytical tools essential for biopharmaceutical production and research. However, the bioprocess services segment is the fastest growing, fueled by the increasing complexity of bioprocesses and the need for outsourcing specialized services like cell line development, process optimization, and regulatory compliance.

Bioprocess Technology Market, By Application

  • Pharmaceuticals
  • Biotechnology
  • Food and Beverage
  • Environmental Management

Based on Application, the Global Bioprocess Technology Market is segmented into Pharmaceuticals, Biotechnology, Food and Beverage and Environmental Management. The pharmaceuticals is the dominating segment, driven by high demand for biopharmaceuticals and advanced therapies. However, the biotechnology segment is the fastest-growing, propelled by innovations in genetic engineering, personalized medicine, and vaccine development.

Bioprocess Technology Market, By End User

  • Biopharmaceutical Companies
  • Academic and Research Institutes
  • Contract Manufacturing Organizations

Based on End User, the Global Bioprocess Technology Market is segmented into Biopharmaceutical Companies, Academic and Research Institutes and Contract Manufacturing Organizations. Biopharmaceutical companies dominate the landscape, as they represent a significant portion of the overall market due to their substantial investments in research and development for drug production. However, the contract manufacturing organizations (CMOs) segment is witnessing the fastest growth, driven by the increasing trend of outsourcing production processes by biopharmaceutical companies looking to reduce costs and improve efficiency.

Bioprocess Technology Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Based on the Geography, the Global Bioprocess Technology Market are classified into North America, Europe, Asia Pacific, and Rest of World. North America is the dominant region in the global bioprocess technology market, driven by its advanced biotechnology infrastructure, robust research and development initiatives, and strong presence of major pharmaceutical companies. The Asia Pacific region is the fastest-growing market for bioprocess technology, driven by rapid industrialization, increasing healthcare demands, and significant investments in biotechnology.

Key Players

The "Global Bioprocess Technology Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Thermo Fisher Scientific Inc., Sartorius AG, Merck KGaA, Danaher Corporation, General Electric Company (GE Healthcare), Eppendorf AG, Lonza Group Ltd., Becton, Dickinson and Company.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

  • Global Bioprocess Technology Market: Recent Developments
  • In August 2024 Merck KGaA announced a strategic partnership with Pfizer to enhance the bioprocessing capabilities for monoclonal antibody production. This collaboration aims to leverage Merck's advanced bioprocess technology platforms to improve efficiency and scalability in drug development.
  • In July 2024 Thermo Fisher Scientific opened a new bioprocessing facility in Massachusetts, aimed at expanding its production capacity for cell culture media and other bioprocessing solutions.
  • In June 2024 Sartorius completed the acquisition of a bioprocessing technology startup that specializes in cell culture systems. This acquisition aligns with Sartorius's strategy to strengthen its portfolio of innovative solutions for biopharmaceutical manufacturing.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 MARKET DEFINITION
  • 1.2 MARKET SEGMENTATION
  • 1.3 RESEARCH TIMELINES
  • 1.4 ASSUMPTIONS
  • 1.5 LIMITATIONS

2 RESEARCH METHODOLOGY

  • 2.1 DATA MINING
  • 2.2 SECONDARY RESEARCH
  • 2.3 PRIMARY RESEARCH
  • 2.4 SUBJECT MATTER EXPERT ADVICE
  • 2.5 QUALITY CHECK
  • 2.6 FINAL REVIEW
  • 2.7 DATA TRIANGULATION
  • 2.8 BOTTOM-UP APPROACH
  • 2.9 TOP-DOWN APPROACH
  • 2.10 RESEARCH FLOW
  • 2.11 DATA SOURCES
  • 2.12 KEY INSIGHTS FROM INDUSTRY EXPERTS

3 EXECUTIVE SUMMARY

  • 3.1 MARKET OVERVIEW
  • 3.2 GLOBAL BIOPROCESS TECHNOLOGY ECOLOGY MAPPING
  • 3.3 GLOBAL BIOPROCESS TECHNOLOGY MARKET ATTRACTIVENESS
  • 3.4 GLOBAL BIOPROCESS TECHNOLOGY ABSOLUTE MARKET OPPORTUNITY
  • 3.5 GLOBAL BIOPROCESS TECHNOLOGY MARKET GEOGRAPHICAL INSIGHTS
  • 3.6 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY TYPE(USD MILLION)
  • 3.7 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION (USD MILLION)
  • 3.8 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY END USER (USD MILLION)
  • 3.9 FUTURE MARKET OPPORTUNITIES
  • 3.10 GLOBAL MARKET SPLIT

4 MARKET OUTLOOK

  • 4.1 GLOBAL BIOPROCESS TECHNOLOGY MARKET OUTLOOK
  • 4.2 MARKET DRIVERS
    • 4.2.1 RISE IN DISEASE BURDEN.
    • 4.2.2 ONGOING TREND OF OUTSOURCING OF BIOPROCESS DEVELOPMENT
  • 4.3 MARKET RESTRAINT
    • 4.3.1 HIGH CAPITAL INVESTMENT AND HIGH COST OF INSTRUMENTS
    • 4.3.2 STRINGENT GOVERNMENT REGULATIONS.
  • 4.4 OPPORTUNITIES
    • 4.4.1 RISE IN RESEARCH AND DEVELOPMENT INVESTMENT FOR BIOTECHNOLOGY
    • 4.4.2 ROBUST BIOPHARMACEUTICAL PIPELINE
  • 4.5 IMPACT OF COVID19 ON THE GLOBAL MARKET
  • 4.6 PORTER'S FIVE FORCES ANALYSIS
    • 4.6.1 THREAT OF NEW ENTRANTS
    • 4.6.2 THREAT OF SUBSTITUTES
    • 4.6.3 BARGAINING POWER OF SUPPLIERS
    • 4.6.4 BARGAINING POWER OF BUYERS
    • 4.6.5 INTENSITY OF COMPETITIVE RIVALRY
  • 4.7 MACROECONOMIC ANALYSIS
  • 4.8 VALUE CHAIN ANALYSIS

5 MARKET, BY PRODUCT

  • 5.1 OVERVIEW
  • 5.2 Bioprocess Instruments
  • 5.3 Bioprocess Services

6 MARKET, BY APPLICATION

  • 6.1 OVERVIEW
  • 6.2 Pharmaceuticals
  • 6.3 Biotechnology
  • 6.4 Food and Beverage
  • 6.5 Environmental Management

7 MARKET, BY END-USER

  • 7.1 OVERVIEW
  • 7.2 Biopharmaceutical Companies
  • 7.3 Academic and Research Institutes
  • 7.4 Contract Manufacturing Organizations

8 MARKET, BY GEOGRAPHY

  • 8.1 OVERVIEW
  • 8.2 NORTH AMERICA
    • 8.2.1 NORTH AMERICA MARKET SNAPSHOT
    • 8.2.2 U.S.
    • 8.2.3 CANADA
    • 8.2.4 MEXICO
  • 8.3 EUROPE
    • 8.3.1 EUROPE MARKET SNAPSHOT
    • 8.3.2 GERMANY
    • 8.3.3 U.K.
    • 8.3.4 FRANCE
    • 8.3.5 ITALY
    • 8.3.6 SPAIN
    • 8.3.7 REST OF EUROPE
  • 8.4 ASIA PACIFIC
    • 8.4.1 ASIA PACIFIC MARKET SNAPSHOT
    • 8.4.2 CHINA
    • 8.4.3 JAPAN
    • 8.4.4 INDIA
    • 8.4.5 REST OF APAC
  • 8.5 LATIN AMERICA
    • 8.5.1 LATIN AMERICA MARKET SNAPSHOT
    • 8.5.2 BRAZIL
    • 8.5.3 ARGENTINA
    • 8.5.4 REST OF LATIN AMERICA
  • 8.6 MIDDLE EAST AND AFRICA
    • 8.6.1 MIDDLE EAST AND AFRICA MARKET SNAPSHOT
    • 8.6.2 UAE
    • 8.6.3 SAUDI ARABIA
    • 8.6.4 SOUTH AFRICA
    • 8.6.5 REST OF MIDDLE EAST AND AFRICA

9 COMPETITIVE LANDSCAPE

  • 9.1 OVERVIEW
  • 9.2 COMPETITIVE SCENARIO
  • 9.3 COMPANY MARKET RANKING ANALYSIS
  • 9.4 COMPANY REGIONAL FOOTPRINT
  • 9.5 COMPANY INDUSTRY FOOTPRINT
  • 9.6 ACE MATRIX
    • 9.6.1 ACTIVE
    • 9.6.2 CUTTING EDGE
    • 9.6.3 EMERGING
    • 9.6.4 INNOVATORS

10 COMPANY PROFILES

  • 10.1 GE HEALTHCARE COMPANY
    • 10.1.1 COMPANY OVERVIEW
    • 10.1.2 COMPANY INSIGHTS
    • 10.1.3 SEGMENT BREAKDOWN
    • 10.1.4 PRODUCT BENCHMARKING
    • 10.1.5 KEY DEVELOPMENTS
    • 10.1.6 SWOT ANALYSIS
    • 10.1.7 WINNING IMPERATIVES
    • 10.1.8 CURRENT FOCUS & STRATEGIES
    • 10.1.9 THREAT FROM COMPETITION
  • 10.2 THERMO FISHER SCIENTIFIC
    • 10.2.1 COMPANY OVERVIEW
    • 10.2.2 COMPANY INSIGHTS
    • 10.2.1 SEGMENT BREAKDOWN
    • 10.2.2 PRODUCT BENCHMARKING
    • 10.2.3 KEY DEVELOPMENTS
    • 10.2.4 WINNING IMPERATIVES
    • 10.2.5 CURRENT FOCUS & STRATEGIES
    • 10.2.6 THREAT FROM COMPETITION
    • 10.2.7 SWOT ANALYSIS
  • 10.3 DANAHER CORPORATION
    • 10.3.1 COMPANY OVERVIEW
    • 10.3.2 COMPANY INSIGHTS
    • 10.3.3 SEGMENT BREAKDOWN
    • 10.3.4 PRODUCT BENCHMARKING
    • 10.3.5 WINNING IMPERATIVES
    • 10.3.6 CURRENT FOCUS & STRATEGIES
    • 10.3.7 THREAT FROM COMPETITION
    • 10.3.8 SWOT ANALYSIS
  • 10.4 LCG GROUP
    • 10.4.1 COMPANY OVERVIEW
    • 10.4.2 COMPANY INSIGHTS
    • 10.4.3 PRODUCT BENCHMARKING
  • 10.5 MERCK GROUP
    • 10.5.1 COMPANY OVERVIEW
    • 10.5.2 COMPANY INSIGHTS
    • 10.5.3 SEGMENT BREAKDOWN
    • 10.5.4 PRODUCT BENCHMARKING
  • 10.6 LONZA GROUP AG
    • 10.6.1 COMPANY OVERVIEW
    • 10.6.2 COMPANY INSIGHTS
    • 10.6.3 SEGMENT BREAKDOWN
    • 10.6.4 PRODUCT BENCHMARKING
  • 10.7 SARTORIUS AG.
    • 10.7.1 COMPANY OVERVIEW
    • 10.7.2 COMPANY INSIGHTS
    • 10.7.3 SEGMENT BREAKDOWN
    • 10.7.4 PRODUCT BENCHMARKING
  • 10.8 CORNING INCORPORATED
    • 10.8.1 COMPANY OVERVIEW
    • 10.8.2 COMPANY INSIGHTS
    • 10.8.3 SEGMENT BREAKDOWN
    • 10.8.4 PRODUCT BENCHMARKING
  • 10.9 BIO-RAD LABORATORIES, INC.
    • 10.9.1 COMPANY OVERVIEW
    • 10.9.2 COMPANY INSIGHTS
    • 10.9.3 SEGMENT BREAKDOWN
    • 10.9.4 PRODUCT BENCHMARKING

LIST OF TABLES

  • TABLE1 PROJECTED REAL GDP GROWTH (ANNUAL PERCENTAGE CHANGE) OF KEY COUNTRIES
  • TABLE 2 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 3 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLES & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 4 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 5 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 6 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY END-USER, 2022 - 2030 (USD MILLION)
  • TABLE 7 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY GEOGRAPHY, 2022 - 2030 (USD MILLION)
  • TABLE 8 NORTH AMERICA BIOPROCESS TECHNOLOGY MARKET, BY COUNTRIES, 2022 - 2030 (USD MILLION)
  • TABLE 9 NORTH AMERICA BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE10 NORTH AMERICA BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE11 NORTH AMERICA BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE12 NORTH AMERICA BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE13 NORTH AMERICA BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE14 U.S. BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE15 U.S. BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE16 U.S. BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE17 U.S.BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE18 U.S.BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE19 CANADABIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 20 CANADA BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 21 CANADA BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 22 CANADA BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 23 CANADA BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE 24 MEXICO BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 25 MEXICO BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 26 MEXICO BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 27 MEXICO BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 28 MEXICO BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE 29 EUROPE BIOPROCESS TECHNOLOGY MARKET, BY COUNTRY, 2022 - 2030 (USD MILLION)
  • TABLE 30 EUROPE BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 31 EUROPEBIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 32 EUROPE BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 33 EUROPE BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 34 EUROPE BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE 35 GERMANY BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 36 GERMANY BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 37 GERMANY BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 38 GERMANY BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 39 GERMANY BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE 40 U.K BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 41 U.K BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 42 U.K BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 43 U.K BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 44 U.K BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE 45 FRANCE BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 46 FRANCE BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 47 FRANCE BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 48 FRANCE BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 49 FRANCE BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE 50 ITALY BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 51 ITALY BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 52 ITALY BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 53 ITALY BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 54 ITALY BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE 55 SPAIN BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 56 SPAIN BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 57 SPAIN BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 58 SPAIN BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 59 SPAIN BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE 60 REST OF EUROPE BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 61 REST OF EUROPE BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 62 REST OF EUROPE BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 63 REST OF EUROPE BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 64 REST OF EUROPE BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE 65 ASIA PACIFIC BIOPROCESS TECHNOLOGY MARKET, BY COUNTRY, 2022 - 2030 (USD MILLION)
  • TABLE 66 ASIA-PACIFICBIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 67 ASIA-PACIFICBIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 68 ASIA-PACIFICBIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 69 ASIA-PACIFIC BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 70 ASIA-PACIFIC BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE 71 CHINA BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 72 CHINA BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 73 CHINA BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 74 CHINA BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 75 CHINA BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE 76 JAPAN BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 77 JAPAN BIOPROCESS TECHNOLOGY MARKET, BY CONSUMAABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 78 JAPAN BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 79 JAPAN BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 80 JAPAN BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE 81 INDIA BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 82 INDIA BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE A& ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 83 INDIA BIOPROCESS TECHNOLOGY MARKET, BY INTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 84 INDIABIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 85 INDIA BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE 86 REST OF ASIA-PACIFIC BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 87 REST OF ASIA PACIFICBIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 88 REST OF ASIA-PACIFICBIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 89 REST OF ASIA-PACIFICBIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 90 REST OF ASIA-PACIFICBIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE 91 LATIN AMERICA BIOPROCESS TECHNOLOGY MARKET, BY COUNTRY, 2022 - 2030 (USD MILLION)
  • TABLE 92 LATIN AMERICA BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 93 LATIN AMERICA BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 94 LATIN AMERICABIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 95 LATIN AMERICA BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 96 LATIN AMERICA BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE 97 BRAZIL BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 98 BRAZIL BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 99 BRAZIL BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE100 BRAZIL BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE101 BRAZIL BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE102 ARGENTINA BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE103 ARGENTINA BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE104 ARGENTINA BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE105 ARGENTINA BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE106 ARGENTINA BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE107 REST OF LATIN AMERICA BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE108 REST OF LATIN AMERICA BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE109 REST OF LATIN AMERICA BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE110 REST OF LATIN AMERICA BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE111 REST OF LATIN AMERICA BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION
  • TABLE112 MIDDLE EAST AND AFRICA BIOPROCESS TECHNOLOGY MARKET, BY COUNTRY, 2022 - 2030 (USD MILLION)
  • TABLE113 MIDDLE EAST & AFRICA BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE114 MIDDLE EAST & AFRICABIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE115 MIDDLE EAST & AFRICABIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE116 MIDDLE EAST & AFRICABIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE117 MIDDLE EAST & AFRICA BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE118 UAE BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE119 UAE BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE120 UAE BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE121 UAE BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE122 UAE BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE123 SAUDI ARABIA BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE124 SAUDI ARABIA BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE125 SAUDI ARABIA BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE126 SAUDI ARABIA BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE127 SAUDI ARABIA BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE128 SOUTH AFRICA BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE129 SOUTH AFRICA BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE130 SOUTH AFRICA BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE131 SOUTH AFRICA BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE132 SOUTH AFRICA BIOPROCESS TECHNOLOGY MARKET, BY END-USER, 2022 - 2030 (USD MILLION)
  • TABLE133 REST OF MEA BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE134 REST OF MEA BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE135 REST OF MEA BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE136 REST OF MEA BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE137 REST OF MEA BIOPROCESS TECHNOLOGY MARKET, BY END-USER, 2022 - 2030 (USD MILLION)
  • TABLE138 COMPANY MARKET RANKING ANALYSIS
  • TABLE139 COMPANY REGIONAL FOOTPRINT
  • TABLE140 COMPANY INDUSTRY FOOTPRINT
  • TABLE141 GE HEALTHCARE COMPANY: PRODUCT BENCHMARKING
  • TABLE142 GE HEALTHCARE: KEY DEVELOPMENTS
  • TABLE143 GE HEALTHCARE: WINNING IMPERATIVES
  • TABLE144 THERMO FISHER SCIENTIFIC: PRODUCT BENCHMARKING
  • TABLE145 THERMO FISHER SCIENTIFIC: KEY DEVELOPMENTS
  • TABLE146 THERMO FISHER SCIENTIFIC: WINNING IMPERATIVES
  • TABLE147 DANAHER CORPORATION: PRODUCT BENCHMARKING
  • TABLE148 DANAHER CORPORATION: WINNING IMPERATIVES
  • TABLE149 LCG GROUP: PRODUCT BENCHMARKING
  • TABLE150 MERCK GROUP: PRODUCT BENCHMARKING
  • TABLE151 LONZA GROUP AG: PRODUCT BENCHMARKING
  • TABLE152 SARTORIUS AG: PRODUCT BENCHMARKING
  • TABLE153 CORNING INCORPORATED: PRODUCT BENCHMARKING
  • TABLE154 BIO-RAD LABORATORIES, INC.: PRODUCT BENCHMARKING

LIST OF FIGURES

  • FIGURE1 GLOBAL BIOPROCESS TECHNOLOGY MARKET SEGMENTATION
  • FIGURE 2 RESEARCH TIMELINES
  • FIGURE 3 DATA TRIANGULATION
  • FIGURE 4 MARKET RESEARCH FLOW
  • FIGURE 5 DATA SOURCES
  • FIGURE 6 KEY INSIGHTS FROM INDUSTRY EXPERTS
  • FIGURE 7 GLOBAL BIOPROCESS TECHNOLOGY MARKET GEOGRAPHICALINSIGHTS, 2023-2030
  • FIGURE 8 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BYTYPE(USD MILLION)
  • FIGURE 9 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION (USD MILLION)
  • FIGURE10 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY END USER (USD MILLION)
  • FIGURE11 FUTURE MARKET OPPORTUNITIES
  • FIGURE12 NORTH AMERICA DOMINATED THE MARKET IN 2021
  • FIGURE13 GLOBAL BIOPROCESS TECHNOLOGY MARKET OUTLOOK
  • FIGURE14 PORTER'S FIVE FORCES ANALYSIS
  • FIGURE15 VALUE CHAIN ANALYSIS
  • FIGURE16 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY TYPE
  • FIGURE17 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION
  • FIGURE18 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY END-USER
  • FIGURE19 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY GEOGRAPHY, 2022 - 2030 (USD MILLION)
  • FIGURE 20 KEY STRATEGIC DEVELOPMENTS
  • FIGURE 21 ACE MATRIX
  • FIGURE 22 GE HEALTHCARE: COMPANY INSIGHT
  • FIGURE 23 GE HEALTHCARE COMPANY: BREAKDOWN
  • FIGURE 24 GE HEALTHCARE: SWOT ANALYSIS
  • FIGURE 25 THERMO FISHER SCIENTIFIC: COMPANY INSIGHT
  • FIGURE 26 THERMO FISHER SCIENTIFIC: BREAKDOWN
  • FIGURE 27 THERMO FISHER SCIENTIFIC: SWOT ANALYSIS
  • FIGURE 28 DANAHER CORPORATION: COMPANY INSIGHT
  • FIGURE 29 DANAHER CORPORATION: BREAKDOWN
  • FIGURE 30 DANAHER CORPORATION: SWOT ANALYSIS
  • FIGURE 31 LCG GROUP: COMPANY INSIGHT
  • FIGURE 32 MERCK GROUP: COMPANY INSIGHT
  • FIGURE 33 MERCK GROUP: BREAKDOWN
  • FIGURE 34 LONZA GROUP AG: COMPANY INSIGHT
  • FIGURE 35 LONZA GROUP AG: BREAKDOWN
  • FIGURE 36 SARTORIUS AG: COMPANY INSIGHT
  • FIGURE 37 SARTORIUS AG: BREAKDOWN
  • FIGURE 38 CORNING INCORPORATED: COMPANY INSIGHT
  • FIGURE 39 CORNING INCORPORATED: BREAKDOWN
  • FIGURE 40 BIO-RAD LABORATORIES, INC.: COMPANY INSIGHT
  • FIGURE 41 CORNING INCORPORATED: BREAKDOWN